Enanta Pharmaceuticals (ENTA) Net Income Growth (1y) (2013 - 2026)
Enanta Pharmaceuticals (ENTA) Net Income Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-43.69% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-73.01% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-290.15% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Enanta Pharmaceuticals |
365.48 Mn |
201.71 Mn |
- |
42.19% |
| Date | Value |
|---|
| Mar 31, 2026 |
42.19% |
| Dec 31, 2025 |
46.44% |
| Sep 30, 2025 |
34.68% |
| Jun 30, 2025 |
19.43% |
| Mar 31, 2025 |
27.32% |
| Dec 31, 2024 |
33.28% |
| Sep 30, 2024 |
-1.86% |
| Jun 30, 2024 |
42.00% |
| Mar 31, 2024 |
17.26% |
| Dec 31, 2023 |
-15.25% |
| Sep 30, 2023 |
-6.68% |
| Jun 30, 2023 |
-23.23% |
| Mar 31, 2023 |
-12.10% |
| Dec 31, 2022 |
3.75% |
| Sep 30, 2022 |
67.83% |
| Jun 30, 2022 |
-31.95% |
| Mar 31, 2022 |
7.37% |
| Dec 31, 2021 |
-261.61% |
| Sep 30, 2021 |
-179.14% |
| Jun 30, 2021 |
-68.41% |
